In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

China's largest drug distributor Sinopharm goes public

Executive Summary

Sinopharm Group, the largest drug distributor in China, has completed its initial public offering on the Hong Kong stock exchange. It grossed HKD8.73bn ($1.13bn) by selling 546mm shares for HKD16, the high end of its planned HKD12.25-16 price range.
Deal Industry
  • Distributors
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies